359 related articles for article (PubMed ID: 12845304)
1. Focal hepatic lesions: evaluation with contrast-enhanced gray-scale harmonic US.
Jang HJ; Lim HK; Lee WJ; Kim SH; Kim MJ; Choi D; Lee SJ; Lim JH
Korean J Radiol; 2003; 4(2):91-100. PubMed ID: 12845304
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of hepatic focal nodular hyperplasia with contrast-enhanced gray scale harmonic sonography: initial experience.
Kim MJ; Lim HK; Kim SH; Choi D; Lee WJ; Lee SJ; Lim JH
J Ultrasound Med; 2004 Feb; 23(2):297-305. PubMed ID: 14992369
[TBL] [Abstract][Full Text] [Related]
3. Characterization of hepatic tumors: value of contrast-enhanced coded phase-inversion harmonic angio.
Wen YL; Kudo M; Zheng RQ; Ding H; Zhou P; Minami Y; Chung H; Kitano M; Kawasaki T; Maekawa K
AJR Am J Roentgenol; 2004 Apr; 182(4):1019-26. PubMed ID: 15039180
[TBL] [Abstract][Full Text] [Related]
4. Focal hepatic masses: enhancement patterns with SH U 508A and pulse-inversion US.
Dill-Macky MJ; Burns PN; Khalili K; Wilson SR
Radiology; 2002 Jan; 222(1):95-102. PubMed ID: 11756711
[TBL] [Abstract][Full Text] [Related]
5. Focal hepatic lesions: contrast-enhancement patterns at pulse-inversion harmonic US using a microbubble contrast agent.
Kim EA; Yoon KH; Lee YH; Kim HW; Juhng SK; Won JJ
Korean J Radiol; 2003; 4(4):224-33. PubMed ID: 14726639
[TBL] [Abstract][Full Text] [Related]
6. Differential patterns of contrast enhancement in different focal liver lesions after injection of the microbubble US contrast agent SonoVue.
Quaia E; Degobbis F; Tona G; Mosconi E; Bertolotto M; Pozzi Mucelli R
Radiol Med; 2004 Mar; 107(3):155-65. PubMed ID: 15031681
[TBL] [Abstract][Full Text] [Related]
7. Harmonic hepatic US with microbubble contrast agent: initial experience showing improved characterization of hemangioma, hepatocellular carcinoma, and metastasis.
Wilson SR; Burns PN; Muradali D; Wilson JA; Lai X
Radiology; 2000 Apr; 215(1):153-61. PubMed ID: 10751481
[TBL] [Abstract][Full Text] [Related]
8. Contrast-enhanced agent detection imaging: value in the characterization of focal hepatic lesions.
Youk JH; Kim CS; Lee JM
J Ultrasound Med; 2003 Sep; 22(9):897-910. PubMed ID: 14510261
[TBL] [Abstract][Full Text] [Related]
9. Tumor-specific vascularization pattern of liver metastasis, hepatocellular carcinoma, hemangioma and focal nodular hyperplasia in the differential diagnosis of 1,349 liver lesions in contrast-enhanced ultrasound (CEUS).
Strobel D; Seitz K; Blank W; Schuler A; Dietrich CF; von Herbay A; Friedrich-Rust M; Bernatik T
Ultraschall Med; 2009 Aug; 30(4):376-82. PubMed ID: 19688669
[TBL] [Abstract][Full Text] [Related]
10. Hepatic tumors: contrast agent-enhancement patterns with pulse-inversion harmonic US.
Kim TK; Choi BI; Han JK; Hong HS; Park SH; Moon SG
Radiology; 2000 Aug; 216(2):411-7. PubMed ID: 10924562
[TBL] [Abstract][Full Text] [Related]
11. Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence.
Quaia E; Calliada F; Bertolotto M; Rossi S; Garioni L; Rosa L; Pozzi-Mucelli R
Radiology; 2004 Aug; 232(2):420-30. PubMed ID: 15286314
[TBL] [Abstract][Full Text] [Related]
12. Characterization of focal hepatic lesions in cirrhotic patients by Pulse Inversion Harmonic Imaging US contrast specific technique with Levovist.
Quaia E; Forgács B; Calderan L; Bertolotto M; Pozzi Mucelli R
Radiol Med; 2002 Oct; 104(4):285-94. PubMed ID: 12569309
[TBL] [Abstract][Full Text] [Related]
13. Differential diagnosis of hepatic tumors: value of contrast-enhanced harmonic sonography using the newly developed contrast agent, Sonazoid.
Hatanaka K; Kudo M; Minami Y; Ueda T; Tatsumi C; Kitai S; Takahashi S; Inoue T; Hagiwara S; Chung H; Ueshima K; Maekawa K
Intervirology; 2008; 51 Suppl 1():61-9. PubMed ID: 18544950
[TBL] [Abstract][Full Text] [Related]
14. US characterization of focal hepatic lesions with intermittent high-acoustic-power mode and contrast material.
Quaia E; Bertolotto M; Calderan L; Mosconi E; Mucelli RP
Acad Radiol; 2003 Jul; 10(7):739-50. PubMed ID: 12862283
[TBL] [Abstract][Full Text] [Related]
15. [Characterization of focal liver lesions with contrast-enhanced low MI real time ultrasound and SonoVue].
Hohmann J; Skrok J; Puls R; Albrecht T
Rofo; 2003 Jun; 175(6):835-43. PubMed ID: 12811698
[TBL] [Abstract][Full Text] [Related]
16. Characterization of unifocal liver lesions with pulse inversion harmonic imaging after Levovist injection: preliminary results.
Bertolotto M; Dalla Palma L; Quaia E; Locatelli M
Eur Radiol; 2000; 10(9):1369-76. PubMed ID: 10997422
[TBL] [Abstract][Full Text] [Related]
17. Differential diagnosis of hepatic tumors by using contrast enhancement patterns at US.
Isozaki T; Numata K; Kiba T; Hara K; Morimoto M; Sakaguchi T; Sekihara H; Kubota T; Shimada H; Morizane T; Tanaka K
Radiology; 2003 Dec; 229(3):798-805. PubMed ID: 14563903
[TBL] [Abstract][Full Text] [Related]
18. Superb microvascular imaging technology for ultrasound examinations: Initial experiences for hepatic tumors.
Lee DH; Lee JY; Han JK
Eur J Radiol; 2016 Nov; 85(11):2090-2095. PubMed ID: 27776663
[TBL] [Abstract][Full Text] [Related]
19. Do different types of liver lesions differ in their uptake of the microbubble contrast agent SH U 508A in the late liver phase? Early experience.
Blomley MJ; Sidhu PS; Cosgrove DO; Albrecht T; Harvey CJ; Heckemann RA; Butler-Barnes J; Eckersley RJ; Basilico R
Radiology; 2001 Sep; 220(3):661-7. PubMed ID: 11526264
[TBL] [Abstract][Full Text] [Related]
20. Differentiation of focal liver lesions using three-dimensional ultrasonography: retrospective and prospective studies.
Luo W; Numata K; Morimoto M; Nozaki A; Ueda M; Kondo M; Morita S; Tanaka K
World J Gastroenterol; 2010 May; 16(17):2109-19. PubMed ID: 20440851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
